Wanbury Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| WANBURY.BO | THEMISMED.BO | 002349.SZ | 2M7C.F | 300705.SZ | 300584.SZ | |
|---|---|---|---|---|---|---|
| Market cap | 6.52B | 9.36B | 5.93B | 2.87B | 5.33B | 3.96B |
| P/E (TTM) | 11.4 | 23.5 | 25.5 | 14.8 | 16.9 | 55.0 |
| Forward P/E | — | — | 21.0 | — | 7.6 | 31.1 |
| Price/book | 3.9 | 2.4 | 2.0 | 1.2 | 2.7 | 3.6 |
| Dividend yield | — | 0.50% | 1.27% | 3.42% | 3.81% | 0.31% |
| 1-year change | −24.39% | −15.42% | −7.44% | −24.84% | −36.07% | −44.94% |
| Today | −3.19% | +1.22% | +0.56% | +2.61% | +1.43% | +3.06% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All WANBURY.BO news ›Wanbury subsidiary launches berrysoft baby range in India
Wanbury Limited announced that its subsidiary, Wanbury Skin Health Limited, has launched the berrysoft™ baby product range across multiple states in India. This move marks a strategic entry into the paediatric dermatology segment,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- scanx.trade1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.